[vc_row top=”0px” bottom=”20px”][vc_column width=”1/3″ css=”.vc_custom_1718136745676{margin-top: 0px !important;margin-left: 20px !important;}”][vc_heading title=”Pre-Clinical Status” position=”left”][/vc_column][vc_column width=”2/3″ css=”.vc_custom_1718139475669{margin-top: 0px !important;padding-top: 40px !important;padding-right: 10px !important;}”][vc_column_text]Fourteen successful preclinical studies of VentriFlo® at Cleveland Clinic¹ and Dartmouth Medical Center have demonstrated VentriFlo’s pulsatile flow, adequate perfusion of critical organs, and successful weaning in both 3 and 6 hour procedures using a porcine model.
Histological examinations indicated all organs were normal, and there was no evidence of acute ischemic change or thromboembolism.¹
In-vitro studies demonstrate low hemolysis.
¹ASAIO 62nd Annual Conference – poster presented by G. Sunagawa, et al. “New Technology to Achieve True Physiologic Pulsatile Flow during Cardiopulmonary Bypass.” (June 2016; San Francisco, CA)[/vc_column_text][/vc_column][/vc_row][vc_row top=”0px” bottom=”20px”][vc_column width=”1/3″ css=”.vc_custom_1718136772307{margin-top: 0px !important;margin-left: 20px !important;}”][vc_heading title=”Accolades” position=”left”][/vc_column][vc_column width=”2/3″ css=”.vc_custom_1483557705734{margin-top: 0px !important;padding-top: 40px !important;}”][vc_column_text]
VentriFlo Awarded 25K in Pediatric Device Innovation Competition[/vc_column_text][/vc_column][/vc_row][vc_row top=”20px” bottom=”20px”][vc_column width=”1/3″ css=”.vc_custom_1718136928170{margin-left: 20px !important;}”][vc_heading title=”Dr. Jack Copeland on VentriFlo’s Technology” position=”left”][/vc_column][vc_column width=”2/3″ css=”.vc_custom_1483543333898{padding-top: 40px !important;}”][vc_video link=”https://youtu.be/aG1wKiUdDQk” el_width=”70″ align=”center”][/vc_column][/vc_row][vc_row top=”20px” bottom=”20px”][vc_column width=”1/3″ css=”.vc_custom_1718136947871{margin-left: 20px !important;}”][vc_heading title=”Benefits” position=”left”][/vc_column][vc_column width=”2/3″][vc_column_text css=”.vc_custom_1483543344071{padding-top: 40px !important;padding-right: 0px !important;padding-left: 0px !important;}”]
Blood pump technology has evolved from constant continuous flow, to synthetic pulse. Imagine the positive impacts a true pulsatile blood pump could have…
[/vc_column_text][/vc_column][/vc_row][vc_row top=”20px” bottom=”20px”][vc_column width=”1/3″ css=”.vc_custom_1718139555234{margin-left: 20px !important;}”][vc_custom_heading text=”Would it improve microcirculation?” font_container=”tag:h5|text_align:left” use_theme_fonts=”yes” css=”.vc_custom_1482528152462{margin-top: 0px !important;}”][/vc_column][vc_column width=”2/3″][vc_custom_heading text=”~30% of capillary beds do not open during continuous flow extracorporeal circulatory support.” font_container=”tag:h5|text_align:left” use_theme_fonts=”yes” css=”.vc_custom_1497561991649{margin-top: 0px !important;}”][vc_column_text css=”.vc_custom_1718139597278{margin-bottom: 15px !important;padding-right: 20px !important;}”]
AmSECT/AATS Annual Conference 2017
(abstract: CBP Induced Acute Kidney Injury (AKI)
Can Pulsatile Flow Mitigate the Risk?);
Ann Thorac Surg 2012 94(6):2046-53;
J Applied Physiol 2012 112(10) 1727-34;
Am J Physiol Regul Integr Comp Physiol.
2006 290(5):R1153-67;
ASAIO Journal 2005 51(1):30-6;
Artificial Organs 2002 26(11):919-23
[/vc_column_text][/vc_column][/vc_row][vc_row top=”20px” bottom=”20px”][vc_column width=”1/3″ css=”.vc_custom_1718139622481{margin-left: 20px !important;}”][vc_custom_heading text=”Would it improve critical organ perfusion?” font_container=”tag:h5|text_align:left” use_theme_fonts=”yes” css=”.vc_custom_1482528130715{margin-top: 0px !important;}”][/vc_column][vc_column width=”2/3″][vc_custom_heading text=”Both continuous and simulated pulsatile extracorporeal pumps are unable to deliver blood flow in the same manner as the native heart.” font_container=”tag:h5|text_align:left” use_theme_fonts=”yes” css=”.vc_custom_1497562110504{margin-top: 0px !important;}”][vc_column_text css=”.vc_custom_1718139581188{margin-bottom: 15px !important;padding-right: 20px !important;}”]
Artificial Organs 2015 39(1): E1-9;
ASAIO Journal 2005 51(5):600-3;
Ann Thorac Surg 1994 58:1199-204;
Perfusion 1988 3:251-62
[/vc_column_text][vc_custom_heading text=”VentriFlo achieves 84% vs. 36% optimal flow; and >2x capillary perfusion vs. current technology” font_container=”tag:h5|text_align:left” use_theme_fonts=”yes” css=”.vc_custom_1645915473549{margin-top: 0px !important;}”][vc_column_text css=”.vc_custom_1718139614868{margin-bottom: 15px !important;padding-right: 20px !important;}”]
ASAIO Annual Conference 2017 Poster 103
(abstract: Impact of Physiologic Pulsatile Flow on
Microcirculation During Cardiopulmonary Bypass)
[/vc_column_text][/vc_column][/vc_row][vc_row top=”20px” bottom=”20px”][vc_column width=”1/3″ css=”.vc_custom_1718139631913{margin-left: 20px !important;}”][vc_custom_heading text=”Would it decrease complication rates?” font_container=”tag:h5|text_align:left” use_theme_fonts=”yes” css=”.vc_custom_1482528174038{margin-top: 0px !important;}”][/vc_column][vc_column width=”2/3″][vc_custom_heading text=”30-50% of extracorporeal circulatory support patients suffer complications related to inadequate perfusion.” font_container=”tag:h5|text_align:left” use_theme_fonts=”yes” css=”.vc_custom_1497562264015{margin-top: 0px !important;}”][vc_column_text css=”.vc_custom_1718139827933{margin-right: 10px !important;margin-bottom: 15px !important;padding-right: 10px !important;}”]
STS Congenital Heart Surgery Database 2015 Harvest
– Children, Infants and Neonates Executive Summary;
Perioperative Kidney Injury 2015, Chapter 8;
Pediatric Crit Care Med. 2014 15(3): e111–e119
[/vc_column_text][/vc_column][/vc_row][vc_row top=”20px” bottom=”20px”][vc_column width=”1/3″ css=”.vc_custom_1718139655554{margin-left: 20px !important;}”][vc_custom_heading text=”Would it help shorten hospital stays?” font_container=”tag:h5|text_align:left” use_theme_fonts=”yes” css=”.vc_custom_1482528214905{margin-top: 0px !important;}”][/vc_column][vc_column width=”2/3″][vc_custom_heading text=”A comparison of continuous and simulated pulsatile flow during CPB indicates a ~40% reduction in both ICU stays and hospital stays for pediatric patients when using simulated pulsatile flow” font_container=”tag:h5|text_align:left” use_theme_fonts=”yes” css=”.vc_custom_1497562332500{margin-top: 0px !important;}”][vc_column_text css=”.vc_custom_1718139897070{margin-right: 10px !important;margin-bottom: 15px !important;padding-right: 10px !important;}”]
Artificial Organs 2013 37(1):82-6
[/vc_column_text][/vc_column][/vc_row][vc_row top=”20px” bottom=”20px”][vc_column width=”1/3″ css=”.vc_custom_1718139696151{margin-left: 20px !important;}”][vc_custom_heading text=”Would it help improve patient outcomes?” font_container=”tag:h5|text_align:left” use_theme_fonts=”yes” css=”.vc_custom_1482528190330{margin-top: 0px !important;}”][/vc_column][vc_column width=”2/3″][vc_custom_heading text=”40-60% of patients undergoing VA-ECMO do not survive. Further, just 1-2 days of transient AKI negatively impacts survival 5 years later.” font_container=”tag:h5|text_align:left” use_theme_fonts=”yes” css=”.vc_custom_1497562375203{margin-top: 0px !important;}”][vc_column_text css=”.vc_custom_1718139982980{margin-right: 10px !important;margin-bottom: 15px !important;padding-right: 10px !important;}”]
ELSO Jan 2016 report;
ASAIO Journal 2015 61(1):2-7;
Artificial Organs 2015 39(11):926-30;
Ann Thorac Surg 2010 90(4)1142-8
[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_btn title=”Contact Us” color=”sky” align=”center” link=”url:https%3A%2F%2Fventriflo.com%2Fcontact%2F|title:Contact%20Us”][/vc_column][/vc_row]